Pharmacogenomics 2019
DOI: 10.1016/b978-0-12-812626-4.00012-7
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacogenomics in Latin American Populations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 168 publications
0
1
0
Order By: Relevance
“…Research on ethnic group pharmacogenetics in Latin America is still scarce ( Sosa-Macías et al, 2016 ; Leitão et al, 2020 ), but there is evidence of pharmacogenetic differences ( Suarez-Kurtz and Parra, 2018 ). For example, Mestizo populations are not considered a unique group for these types of studies, since miscegenation varies in each Latin American country ( Botton et al, 2019 ).The COVID-19 pandemic has shown us that data and access to pharmacogenetic information are required for making clinical decisions in a prioritized and sometimes urgent ways.…”
Section: Introductionmentioning
confidence: 99%
“…Research on ethnic group pharmacogenetics in Latin America is still scarce ( Sosa-Macías et al, 2016 ; Leitão et al, 2020 ), but there is evidence of pharmacogenetic differences ( Suarez-Kurtz and Parra, 2018 ). For example, Mestizo populations are not considered a unique group for these types of studies, since miscegenation varies in each Latin American country ( Botton et al, 2019 ).The COVID-19 pandemic has shown us that data and access to pharmacogenetic information are required for making clinical decisions in a prioritized and sometimes urgent ways.…”
Section: Introductionmentioning
confidence: 99%